StockWatch
·

KAVERI SEED COMPANY LTD.

BSE: 532899

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
819.29
+830.5%-14.3%
Expenditure
546.76
+385.4%-14.0%
Net Profit
271.30
+1157.9%-14.3%
OPM %
34.51%
+52.12pp+0.41pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-147.46157.91463.28768.651.1KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

The ₹72.5 Crore Quarter: Kaveri Seed's Overstate and Guidance Collapse

guidance-miss · revenue-discrepancy · monsoon-shock

Result verdictFollow-upQ1 FY2719 Aug 20266 minFMCG

Guidance miss masks new products; monsoon-driven miss likely structural

monsoon-shock · product-mix-shift · market-share-loss

TranscriptDeep diveQ1 FY2719 Aug 20266 minFMCG

Kaveri Seed Q1 FY27: consolidated PAT down 14% YoY on 13% revenue decline, margins flat

seeds · agri inputs · kharif season

ResultsQ1 FY2713 Aug 20263 minFMCG
Latest
Board Meeting13 Aug, 1:54 pm

Kaveri Seed Q1 FY27: consolidated PAT down 14% YoY on 13% revenue decline, margins flat

Kaveri Seed's consolidated Q1 FY27 revenue came in at ₹742.50 Cr, down 13.5% YoY from ₹858.53 Cr, with consolidated PAT of ₹279.84 Cr, down 14.5% YoY from ₹327.16 Cr (basic EPS ₹54.40 vs ₹63.76). Standalone tells the same story — revenue ₹815.00 Cr (-13.8% YoY) and PAT ₹271.30 Cr (-14.3% YoY) — so the two statements are directionally aligned, and neither period carries an exceptional item, keeping the comparison clean. Margins held up despite the topline drop: consolidated OPM was ~39.6% versus 39.4% a year ago, and NPM slipped only marginally to ~37.5% from 37.7%, because cost of materials consumed and the inventory-change line fell roughly in step with revenue. The one cost pressure was employee benefits expense, up 21.9% YoY to ₹44.64 Cr (₹36.62 Cr a year ago), which the company has absorbed without denting margins so far. Sequentially, consolidated PAT swung from a ₹27.81 Cr loss in Q4 FY26 to this quarter's ₹279.84 Cr profit, but that reflects the normal kharif-season concentration of sales in Q1 for a seed company rather than an operational turnaround, and should not be read as momentum. No numeric street consensus for the quarter turned up in a search; pre-print commentary (scanx.trade) had flagged expectations of robust growth from cotton, millet and hybrid-rice sales plus export strength, which the actual 13.5% YoY revenue decline runs counter to. Against management's own guidance from the May 2026 (Q4 FY26) concall — 15-20% FY27 revenue growth, cotton outperforming at over 20%, no price hikes, and margin gains from lower costs — this quarter's decline puts the full-year revenue target off-track one quarter in, even as the margin side of the guidance held roughly true. No company press release accompanying this filing was available to check management's own framing of the number against these figures. Corporate developments alongside the print include the CFO's retirement effective July 31, 2026, and a pending ITAT hearing (disclosed August 6, 2026) over a ₹69.5 Cr tax demand, a litigation item not yet reflected in the P&L. With three quarters left in FY27, the company needs a sharp acceleration in Q2-Q4 to reach the guided 15-20% full-year growth band after this double-digit YoY decline in Q1; the ITAT outcome and whether employee-cost growth keeps outpacing revenue are the near-term markers to track.

13 Aug 2026, 01:54 pm

Corporate Events

Board MeetingKSCL
2026
29Sep

Board Meeting

The 39th Annual General Meeting (AGM) of the members of Kave…

BSE Filing
Board MeetingKSCL
2026
13Aug

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing
Board MeetingKSCL
2026
26May

Board Meeting

To consider the Standalone and Consolidated Audited Financia…

BSE Filing
DividendKSCL
2024
13Nov

₹250 / share

BSE Filing
Board MeetingKSCL
2024
13Nov

Board Meeting

Consider the Standalone and Consolidated Un-audited Financia…

BSE Filing
Board MeetingKSCL
2024
22May

Board Meeting

Consideration and approval of Standalone and Consolidated Au…

BSE Filing
Board MeetingKSCL
2024
2Feb

Board Meeting

Consideration and approval of Standalone and Consolidated Un…

BSE Filing
Board MeetingKSCL
2024
5Jan

Board Meeting

Proposal for Buyback of Equity Shares

BSE Filing
DividendKSCL
2023
29Nov

₹5 / share

BSE Filing
DividendKSCL
2023
20Nov

₹5 / share

BSE Filing
Board MeetingKSCL
2023
8Nov

Board Meeting

Consideration of Standalone and Consolidated Un-audited Fina…

BSE Filing
Board MeetingKSCL
2023
14Aug

Board Meeting

Consideration and approval of Standalone and Consolidated Un…

BSE Filing